Platelet activation in depression and effects of sertraline treatment: An open-label study

American Journal of Psychiatry

Volumn 157, Issue 6, 2000, Pages 1006-1008

  Markovitz, Jerome H ^a   Shuster, John L ^a   Chitwood, William S ^a   May, Roberta S ^a   Tolbert, Lelland C ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR; SERTRALINE;

ADULT; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEPRESSION; DRUG EFFECT; FAMILY HISTORY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RECEPTOR BINDING; SCORING SYSTEM; THROMBOCYTE ACTIVATION; THROMBOCYTE RELEASE REACTION;

ADULT; BLOOD PLATELETS; COLLAGEN; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TREATMENT OUTCOME;

EID: 0034125861     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.157.6.1006     Document Type: Article

References (10)

1. Frasure-Smith N, Lesperance F, Talajic M: Depression following myocardial infarction: impact on 6-month survival. JAMA 1993; 270:1819-1825
2. Coller BS: Platelets and thrombolytic therapy. N Engl J Med 1990; 322:33-42
3. Musselman DL, Tomer A, Manatunga AK, Knight BT, Porter MR, Kasey S, Marzec U, Harker LA, Nemeroff CB: Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996; 153:1313-1317
4. Laghrissi-Thode F, Wagner WR, Pollock BG, Johnson PC, Finkel MS: Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry 1997; 42:290-295
5. Markovitz JH, Roubin GS, Parks JM, Bittner V: Platelet activation and restenosis following coronary stenting: flow cytometric detection of wound-induced platelet activation. Coron Artery Dis 1996; 7:657-665
6. Markovitz JH, Tolbert L, Winders S: Increased serotonin receptor density and platelet GPIIb/IIIa activation among smokers. Arteroscler Thromb Vasc Biol 1999; 19:762-766
7. Laghrissi-Thode F, Pollock BG, Wagner WR: Evaluation of platelet activation in depressed patients with ischemic heart disease following paroxetine or nortriptyline treatment. J Clin Psychopharmacol (in press)
8. Stahl S: 5HT1A receptors and pharmacotherapy: is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs? Psychopharmacol Bull 1994; 30: 39-43
9. Sheline YI, Bardgett ME, Jackson JL, Newcomer JW, Csernansky JG: Platelet serotonin markers and depressive symptomatology. Biol Psychiatry 1995; 37:442-447
10. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, Johnson J: Smoking, smoking cessation, and major depression. JAMA 1990; 264:1546-1549